Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma
CompletedOBSERVATIONAL
Enrollment
270
Participants
Timeline
Start Date
June 1, 2021
Primary Completion Date
April 1, 2024
Study Completion Date
June 20, 2024
Conditions
Bladder Cancer RecurrenceIntravesical InstillationUpper Urinary Tract Carcinoma
Trial Locations (1)
06050
Ankara City Hospital Bilkent, Ankara, Ankara 06800, Ankara